HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masato Kanazawa Selected Research

Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy

11/2021Candesartan prevents arteriopathy progression in cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy model.
1/2020HTRA1-Related Cerebral Small Vessel Disease: A Review of the Literature.
1/2019HTRA1 Mutations Identified in Symptomatic Carriers Have the Property of Interfering the Trimer-Dependent Activation Cascade.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masato Kanazawa Research Topics

Disease

10Ischemic Stroke
12/2020 - 03/2011
10Brain Ischemia (Cerebral Ischemia)
10/2020 - 06/2011
7Ischemia
07/2022 - 06/2011
7Stroke (Strokes)
12/2020 - 01/2017
4Hemorrhage
12/2020 - 06/2011
3Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
11/2021 - 01/2019
3Neuroinflammatory Diseases
03/2017 - 07/2015
2Atherosclerosis
09/2021 - 10/2004
2Infarction (Infarctions)
01/2020 - 01/2014
2Edema (Dropsy)
01/2018 - 05/2012
2Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
04/2016 - 07/2015
2hypoglycemic encephalopathy
01/2015 - 08/2013
2Hypoglycemia (Reactive Hypoglycemia)
01/2015 - 08/2013
2Neurodegenerative Diseases (Neurodegenerative Disease)
03/2011 - 03/2007
1Lacunar Stroke
09/2021
1Transient Ischemic Attack
12/2020
1Hypertension (High Blood Pressure)
12/2020
1Inflammation (Inflammations)
12/2020
1Intracranial Arterial Diseases
01/2020
1Vascular Remodeling
03/2017
1Spinal Cord Diseases
02/2016
1Cerebral Infarction
07/2015
1Brain Injuries (Brain Injury)
07/2015
1Hyperglycemia
01/2015
1Coma (Comas)
01/2015
1Multiple Myeloma
01/2014
1Paresis (Hemiparesis)
01/2014
1Fever (Fevers)
01/2014
1Brain Edema (Cerebral Edema)
01/2014
1Cerebral Hemorrhage
05/2012
1TDP-43 Proteinopathies
03/2011
1Chorea (Rheumatic Chorea)
09/2007
1Blepharospasm
03/2007
1Apraxias (Dyspraxia)
03/2007
1Leukocytosis (Pleocytosis)
07/2005
1Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
10/2004
1Mixed Connective Tissue Disease (MCTD)
10/2004
1Neoplasms (Cancer)
08/2004
1Vascular Malformations
08/2004
1Tetanus
11/2003

Drug/Important Bio-Agent (IBA)

7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 06/2011
6Glucose (Dextrose)FDA LinkGeneric
12/2020 - 05/2012
6Tissue Plasminogen Activator (Alteplase)FDA Link
12/2020 - 06/2011
5Oxygen (Dioxygen)IBA
10/2020 - 05/2012
3High-Temperature Requirement A Serine Peptidase 1IBA
11/2021 - 01/2019
3Proteins (Proteins, Gene)FDA Link
11/2021 - 07/2005
3Matrix Metalloproteinase 9 (Gelatinase B)IBA
11/2019 - 06/2011
3Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
11/2019 - 06/2011
3ProgranulinsIBA
03/2017 - 07/2015
2Therapeutic UsesIBA
10/2020 - 07/2015
2Transforming Growth Factors (Transforming Growth Factor)IBA
11/2019 - 01/2017
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2016 - 07/2015
2Interleukin-10 (Interleukin 10)IBA
04/2016 - 07/2015
2DNA (Deoxyribonucleic Acid)IBA
07/2015 - 03/2011
2GadoliniumIBA
01/2014 - 08/2004
1TEMPOIBA
07/2022
1Glutamic Acid (Glutamate)FDA Link
07/2022
1candesartanIBA
11/2021
1Antihypertensive Agents (Antihypertensives)IBA
09/2021
1Pharmaceutical PreparationsIBA
12/2020
1Protective AgentsIBA
12/2020
1Reactive Oxygen Species (Oxygen Radicals)IBA
12/2020
1Laminin (Merosin)IBA
01/2020
1IntegrinsIBA
01/2020
1nilotinibFDA Link
01/2020
1Blood Proteins (Serum Proteins)IBA
01/2018
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
02/2016
1Matrix Metalloproteinases (MMPs)IBA
11/2015
1Cathepsin LIBA
11/2015
1Cathepsin BIBA
11/2015
1Glycoproteins (Glycoprotein)IBA
07/2015
1Neuroprotective AgentsIBA
01/2015
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2015
1Angiopoietin-1IBA
01/2014
1Hemoglobins (Hemoglobin)IBA
01/2014
1Lactic Acid (Lactate)FDA LinkGeneric
08/2013
1Fibronectins (Fibronectin)IBA
05/2012
1AntigensIBA
05/2012
1VitronectinIBA
05/2012
1Peptide Hydrolases (Proteases)FDA Link
05/2012
1Haloperidol (Haldol)FDA LinkGeneric
09/2007
1Type A Botulinum Toxins (Botox)FDA Link
03/2007
1Muramidase (Lysozyme)IBA
07/2005
1Malondialdehyde (Propanedial)IBA
10/2004
1oxidized low density lipoproteinIBA
10/2004
1AntibodiesIBA
10/2004
1AutoantibodiesIBA
10/2004
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
10/2004
1Immunoglobulins (Immunoglobulin)IBA
11/2003

Therapy/Procedure

8Therapeutics
09/2021 - 01/2014
2Cell- and Tissue-Based Therapy (Cell Therapy)
10/2020 - 01/2017
1General Anesthesia
12/2020
1Thrombectomy
12/2020
1Drug Therapy (Chemotherapy)
01/2014
1Injections
03/2007